NEW YORK (Reuters Health) – Reperfusing the myocardium within 5 hours of an infarction makes a real survival difference, research from Denmark shows. The study, conducted in patients…
NEW YORK (Reuters Health) – A study published today provides more evidence that proton pump inhibitors (PPI) interfere with clopidogrel. Recommendations from the Society for Cardiovascular Angiography and…
NEW YORK (Reuters Health) – For patients with acute kidney injury, increasing the intensity of hemodialysis over recommended levels does not reduce mortality or improve renal recovery, according…
NEW YORK (Reuters Health) – Physicians should monitor serum testosterone levels during androgen-deprivation therapy (ADT) in men with prostate cancer, according to an April 16th online report in…
NEW YORK (Reuters Health) – Using recombinant tissue plasminogen activator (rtPA) within existing licensing limits is fully justified by available data – but there’s not enough data to…
NEW YORK (Reuters Health) – The angiotensin II receptor blocker olmesartan medoxomil (Benicar) significantly reduces blood pressure in children with primary or secondary hypertension, according to an international…
NEW YORK (Reuters Health) – Despite the popularity of urethrotomy for treating urethral strictures in men, the success rate is less than 10% initially and may drop to…
NEW YORK (Reuters Health) – Intravenous magnesium sulfate (MgSO4) does not benefit patients with acute aneurysmal subarachnoid hemorrhage, according to results of a phase III trial. In the…
NEW YORK (Reuters Health) – Although promethazine and metoclopramide have similar antiemetic effects in hyperemesis gravidarum, metoclopramide has fewer side effects, according to a study published online April…
NEW YORK (Reuters Health) – Patients with left ventricular (LV) dysfunction should receive human atrial natriuretic peptide (hANP) infusions during coronary artery bypass graft (CABG) surgery, Japanese researchers…